RIMAN
July 2, 2026
RIMAN Korea recorded 198.2 billion won in sales in 2025, placing it sixth among South Korea's multilevel marketing companies, according to annual disclosures released by the Korea Fair Trade Commission on July 1, 2026.
It is the first year RIMAN Korea has appeared in the commission's multilevel statistics. The company was previously registered as a sponsored door-to-door sales business and switched its registration to multilevel sales, which brought it into the data set and into the top ten by revenue.
The top ten companies, in order, were Korea Amway, Atomy, PM-International Korea, Unicity Korea, Nu Skin Korea, RIMAN Korea, Herbalife Korea, USANA Health Sciences Korea, Viable and Charis. Together they accounted for 3.48 trillion won, or 77.1 percent of the market.
Total multilevel sales in Korea fell 0.51 percent to 4.51 trillion won in 2025. RIMAN Korea's inclusion narrowed the decline; excluding it, sales at the remaining companies fell about 4.9 percent.
In May 2025 the commission referred RIMAN Korea and its former chief executive to prosecutors for operating as a multilevel seller without the required registration from March 2020 through November 2024.